Transdermal Glucose Monitoring Interface for CGM Warm-Up Guidance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current continuous glucose monitoring (CGM) systems lack intuitive navigation designs for the device warm-up period, insufficient in improving blood glucose control efficacy, and fail to promptly determine reasons for glucose variations among family members.
Innovation Solution
A transdermal glucose monitoring system with a CGM device, patient user interface, and cloud server, featuring a user-friendly interface with real-time glucose data display, warm-up progress indicators, and data sharing capabilities, enabling family members to monitor and infer glucose fluctuations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a CGM device is implanted subcutaneously to monitor glucose concentration, then continuous glucose monitoring capability is achieved, but a warm-up period is required before accurate measurements can be obtained
Solution Approach 1:
The system performs preliminary actions by displaying warm-up progress indicators before accurate measurement is achieved. The GUI shows warm-up status, estimated time to completion, and progress bars that prepare the user for when accurate readings will be available, allowing the system to maintain measurement reliability while reducing the perceived time loss through proactive information provision.
2Loss of information
If the GUI displays detailed warm-up information and navigation instructions, then user understanding of device status is improved, but interface complexity increases
Solution Approach 1:
The GUI is segmented into distinct functional sections: warm-up status display, glucose concentration display, navigation instructions, and alert notifications. Each section handles specific information independently, allowing the system to provide comprehensive device status information while maintaining interface simplicity through modular organization and clear visual separation of concerns.
3Reliability
If the system provides comprehensive glucose monitoring data and analysis, then blood glucose control efficacy is improved, but data processing and storage requirements increase
Solution Approach 1:
The system extracts and separates critical glucose control information from the complete dataset. It displays only the most relevant parameters (current glucose concentration, warm-up status, key alerts) while storing comprehensive data in the background. This extraction approach enables effective glucose control through essential information without requiring proportional increases in data processing and storage resources.
Data Source
AI summary
A transdermal glucose monitoring system is provided. The system includes: a continuous glucose monitoring (CGM) device, configured to monitor glucose concentration in subcutaneous interstitial fluid of a patient; a patient user interface, configured to acquire information of the CGM device, receive glucose concentration data, and display a warm-up progress indicator of the CGM device; and a cloud server, configured to complete data sharing and authorize access to data. The provided patient user interface focuses on the warm-up time of the CGM device and provides a positive and intuitive display thereof, along with visual management of glucose monitoring data analysis, thereby enhancing the convenience of glucose monitoring. Furthermore, the system supports a second monitoring device, enabling family and friends to promptly understand the patient's glucose monitoring status and infer the causes of glucose fluctuations.